← Back to Search

Diagnostic Procedure

immunohistochemistry staining method for Testicular Cancer

N/A
Waitlist Available
Research Sponsored by Eastern Cooperative Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up observed at least annually
Awards & highlights

Summary

RATIONALE: Diagnostic procedures may improve a doctor's ability to predict the recurrence of testicular cancer. PURPOSE: Diagnostic trial to detect the risk of recurrent disease in patients who have stage I testicular cancer and who have undergone orchiectomy within the previous 12 weeks.

Eligible Conditions
  • Testicular Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~observed at least annually
This trial's timeline: 3 weeks for screening, Varies for treatment, and observed at least annually for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evidence of regional or metastatic spread

Trial Design

1Treatment groups
Active Control
Group I: Laboratory/CT evaluationActive Control3 Interventions
Observation following orchiectomy

Find a Location

Who is running the clinical trial?

Eastern Cooperative Oncology GroupLead Sponsor
268 Previous Clinical Trials
151,519 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,872 Previous Clinical Trials
41,010,701 Total Patients Enrolled
5 Trials studying Testicular Cancer
65,613 Patients Enrolled for Testicular Cancer
Richard S. Foster, MDStudy ChairIndiana University Melvin and Bren Simon Cancer Center
~3 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top